Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Guangdong Topstar Technology
300607
5
Hengerda New Materials
300946
CN Stock MarketDetailed Quotes
300753 Jiangsu Apon Medical Technology
- 23.62
- +1.22+5.45%
Market Closed May 12 15:00 CST
2.98BMarket Cap-363.38P/E (TTM)
24.18High23.02Low209.54KlotVolume23.59Open22.40Pre Close493.73MTurnover25.42%Turnover Ratio274.65P/E (Static)126.05MShares30.9752wk High4.37P/B1.95BFloat Cap10.0652wk Low26.88Limit Up82.43MShs Float35.93Historical High17.92Limit Down5.18%Amplitude7.92Historical Low0.07Dividend TTM23.56Avg Price92.97KlotAsk0.28%Div YieldTTM100Lot Size103.63KlotBid
Jiangsu Apon Medical Technology Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 4.74%72.29M | 14.24%437.11M | 15.09%302.62M | 17.56%211.62M | -13.80%69.02M | -5.01%382.62M | 21.84%262.95M | 18.07%180.01M | 7.41%80.06M | -17.71%402.81M |
| Refunds of taxes and levies | 1,466.31%2.15M | 51.23%16.75M | -29.54%7.03M | -28.45%6.69M | -98.02%137.31K | 52.02%11.08M | 65.38%9.98M | 83.84%9.34M | 166.34%6.93M | -8.20%7.29M |
| Cash received relating to other operating activities | -62.41%1.23M | 21.07%10.89M | 39.44%7.33M | 75.33%4.39M | 292.24%3.29M | -38.90%9M | -40.26%5.26M | -51.82%2.5M | -10.77%837.57K | 35.49%14.73M |
| Cash inflows from operating activities | 4.47%75.68M | 15.41%464.76M | 13.95%316.99M | 16.07%222.7M | -17.53%72.44M | -5.21%402.7M | 20.61%278.18M | 17.89%191.86M | 12.49%87.83M | -16.43%424.82M |
| Goods services cash paid | -49.58%22.43M | 6.87%152.24M | -2.13%120.45M | -18.11%71.98M | -18.94%44.48M | -18.02%142.45M | 17.98%123.07M | 15.35%87.89M | 34.07%54.88M | -15.51%173.75M |
| Staff behalf paid | -13.89%38.04M | -0.56%124.65M | -4.13%96.37M | -1.01%70.13M | 0.95%44.18M | -7.68%125.35M | -5.70%100.52M | -9.90%70.85M | -9.69%43.76M | 8.46%135.78M |
| All taxes paid | 62.27%15.62M | 35.18%45.43M | 32.39%31.89M | 1.52%18.54M | -7.23%9.63M | 20.12%33.6M | 15.06%24.09M | 45.75%18.26M | 57.64%10.38M | -46.52%27.98M |
| Cash paid relating to other operating activities | -1.11%37.78M | 1.71%126.76M | 2.97%101.61M | -6.48%64.01M | -3.73%38.21M | 11.37%124.63M | 20.43%98.68M | 32.01%68.44M | -3.38%39.68M | 4.67%111.91M |
| Cash outflows from operating activities | -16.57%113.87M | 5.41%449.08M | 1.15%350.32M | -8.47%224.66M | -8.21%136.49M | -5.20%426.03M | 10.38%346.36M | 11.97%245.45M | 8.51%148.7M | -8.29%449.42M |
| Net cash flows from operating activities | 40.37%-38.2M | 167.19%15.68M | 51.10%-33.34M | 96.35%-1.96M | -5.24%-64.05M | 5.12%-23.34M | 17.98%-68.17M | 5.10%-53.59M | -3.24%-60.87M | -234.49%-24.59M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | ---- | -92.33%1M | -91.69%1M | --1M | ---- | --13.04M | --12.04M | ---- | ---- | ---- |
| Cash received from returns on investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | ---- | 11,523.95%6.6M | 8,059.30%4.47M | 93,052.00%4.47M | ---- | 110.56%56.75K | 1,639.68%54.8K | 52.38%4.8K | ---- | -79.12%26.95K |
| Cash received relating to other investing activities | --1.02M | -43.76%92.76M | -84.10%13.14M | -95.03%1M | ---- | -36.88%164.94M | 67.75%82.65M | -59.12%20.14M | ---- | -29.10%261.31M |
| Cash inflows from investing activities | --1.02M | -43.63%100.36M | -80.35%18.62M | -67.88%6.47M | ---- | -31.87%178.04M | 92.28%94.75M | -59.11%20.15M | ---- | -29.11%261.34M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -44.55%1.8M | -66.72%10.23M | -79.69%4.75M | -80.46%4.1M | -79.66%3.24M | 27.15%30.73M | 9.71%23.38M | 62.45%21M | 57.68%15.92M | -38.97%24.17M |
| Cash paid to acquire investments | ---- | -28.24%6.1M | 480.00%5.8M | --2M | --2M | 183.33%8.5M | -66.67%1M | ---- | ---- | -86.67%3M |
| Cash paid relating to other investing activities | 0.00%92M | -44.24%92M | -27.59%105M | 12.05%93M | -27.56%92M | -36.29%165M | 62.92%145M | -6.74%83M | 159.18%127M | -29.23%259M |
| Cash outflows from investing activities | -3.54%93.8M | -46.96%108.33M | -31.78%115.55M | -4.70%99.1M | -31.96%97.24M | -28.63%204.23M | 49.48%169.38M | -0.89%104M | 130.16%142.92M | -38.51%286.17M |
| Net cash flows from investing activities | 4.59%-92.77M | 69.57%-7.97M | -29.88%-96.93M | -10.48%-92.63M | 31.96%-97.24M | -5.48%-26.19M | -16.55%-74.63M | -50.67%-83.85M | -130.16%-142.92M | 74.33%-24.83M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | 861.11%865K | --90K | --90K | --90K | --90K | ---- | ---- | ---- | ---- | 0.00%50K |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | 861.11%865K | --90K | --90K | --90K | --90K | ---- | ---- | ---- | ---- | 0.00%50K |
| Cash from borrowing | 99.00%19.9M | -1.43%48.4M | 23.47%48.4M | 0.34%29.4M | 1.01%10M | 67.01%49.1M | 33.33%39.2M | 50.26%29.3M | -1.00%9.9M | --29.4M |
| Cash inflows from financing activities | 105.80%20.77M | -1.24%48.49M | 23.70%48.49M | 0.65%29.49M | 1.92%10.09M | 66.72%49.1M | 33.11%39.2M | 50.26%29.3M | -1.00%9.9M | 58,800.00%29.45M |
| Borrowing repayment | --10M | -0.25%39.2M | 33.33%39.2M | -0.51%19.4M | ---- | --39.3M | --29.4M | --19.5M | --10M | ---- |
| Dividend interest payment | 20.30%399.59K | 626.62%9.65M | 822.99%9.29M | 1,331.96%8.91M | 3.05%332.17K | 109.60%1.33M | 178.56%1.01M | 352.23%622.35K | 2,317.46%322.33K | -97.99%633.58K |
| Cash payments relating to other financing activities | -3.10%1.37M | -2.75%6.61M | 7.41%4.04M | 152.95%3.61M | 36.23%1.42M | 38.75%6.8M | 121.23%3.76M | 115.88%1.43M | 145.78%1.04M | 11.69%4.9M |
| Cash outflows from financing activities | 572.52%11.77M | 16.94%55.46M | 53.73%52.53M | 48.14%31.93M | -84.59%1.75M | 757.18%47.43M | 1,557.24%34.17M | 2,595.82%21.55M | 2,500.41%11.36M | -84.59%5.53M |
| Net cash flows from financing activities | 7.81%8.99M | -516.28%-6.97M | -180.21%-4.04M | -131.43%-2.44M | 669.77%8.34M | -93.00%1.67M | -81.63%5.03M | -58.56%7.75M | -115.31%-1.46M | 166.72%23.92M |
| Net cash flow | ||||||||||
| Net increase in cash and cash equivalents | 20.25%-121.98M | 101.54%738.91K | 2.52%-134.31M | 25.19%-97.02M | 25.48%-152.95M | -87.59%-47.86M | -15.03%-137.77M | -38.82%-129.69M | -84.09%-205.25M | 77.68%-25.51M |
| Add:Begin period cash and cash equivalents | 0.37%201.64M | -19.24%200.9M | -19.24%200.9M | -19.24%200.9M | -19.24%200.9M | -9.30%248.75M | -9.30%248.75M | -9.30%248.75M | -9.30%248.75M | -29.42%274.26M |
| End period cash equivalent | 66.14%79.66M | 0.37%201.63M | -40.00%66.59M | -12.76%103.87M | 10.21%47.94M | -19.24%200.9M | -28.17%110.98M | -34.16%119.07M | -73.27%43.5M | -9.30%248.75M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting